← Back to headlines
D. Boral Capital Downgrades Plus Therapeutics (PSTV) to Hold
D. Boral Capital has downgraded its rating for Plus Therapeutics (PSTV) to Hold.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
